Search company, investor...


Series D | Alive

Total Raised


Last Raised

$2.36M | 28 yrs ago

About BioTransplant

BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,

Headquarters Location

101 Washington Street Suite 101 Foxborough, MA 02035 Suite 101

Foxborough, Massachusetts, 02035,

United States



BioTransplant Frequently Asked Questions (FAQ)

  • Where is BioTransplant's headquarters?

    BioTransplant's headquarters is located at 101 Washington Street Suite 101 Foxborough, MA 02035, Foxborough.

  • What is BioTransplant's latest funding round?

    BioTransplant's latest funding round is Series D.

  • How much did BioTransplant raise?

    BioTransplant raised a total of $2.36M.

  • Who are the investors of BioTransplant?

    Investors of BioTransplant include Rho Ventures.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.